SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-043330
Filing Date
2024-11-01
Accepted
2024-11-01 16:15:14
Documents
19
Period of Report
2024-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 56622
2 ex4-1.htm EX-4.1 8919
3 ex4-2.htm EX-4.2 139811
4 ex4-3.htm EX-4.3 25257
5 ex4-4.htm EX-4.4 82563
6 ex10-1.htm EX-10.1 92231
  Complete submission text file 0001493152-24-043330.txt   708162

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cdt-20241028.xsd EX-101.SCH 3883
8 XBRL DEFINITION FILE cdt-20241028_def.xml EX-101.DEF 30185
9 XBRL LABEL FILE cdt-20241028_lab.xml EX-101.LAB 37007
10 XBRL PRESENTATION FILE cdt-20241028_pre.xml EX-101.PRE 27208
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6160
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 241419270
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)